CIK 0001133416 · Non-accelerated filer<br>Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 043562325
- Phone
- 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-23 | FREEMAN KEVIN D Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-01-23 | ELDRED KARY Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-01-23 | CARSON BENJAMIN SR Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-01-23 | CALLICUTT JACK W Chief Financial Officer | Grant or award · Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2025-01-23 | CALLICUTT JACK W Chief Financial Officer | Grant or award · Restricted Stock Unit | +60,000 | 60,000 | ||
| 2025-01-23 | OMENN GILBERT S Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-12-30 | Shlevin Harold H. Director | Purchase | +6,500 | $1.16 | $8K | 15,206 |
| 2024-12-24 | Zordani Richard A. Jr. Director | Purchase | +10,000 | $0.82 | $8K | 42,083 |
| 2024-12-24 | ELDRED KARY Director | Purchase | +13,469 | $0.82 | $11K | 63,682 |
| 2024-12-24 | FREEMAN KEVIN D Director | Purchase | +10,000 | $0.81 | $8K | 44,769 |
| 2024-12-23 | Jamil Khurram Chief Medical Officer | Option exercise 10b5-1 | +40,000 | 40,000 | ||
| 2024-12-23 | Jamil Khurram Chief Medical Officer | Sale 10b5-1 | −13,654 | $0.88 | $12K | 26,346 |
| 2024-12-23 | Jamil Khurram Chief Medical Officer | Option exercise · Restricted Stock Units 10b5-1 | +40,000 | 0 | ||
| 2024-12-23 | LEWIS JOEL President and CEO | Option exercise 10b5-1 | +56,000 | 953,012 | ||
| 2024-12-23 | LEWIS JOEL President and CEO | Sale 10b5-1 | −56,000 | $0.89 | $50K | 897,012 |
| 2024-12-23 | LEWIS JOEL President and CEO | Option exercise · Restricted Stock Units 10b5-1 | +56,000 | 0 | ||
| 2024-12-23 | CALLICUTT JACK W Chief Financial Officer | Option exercise 10b5-1 | +40,000 | 47,614 | ||
| 2024-12-23 | CALLICUTT JACK W Chief Financial Officer | Sale 10b5-1 | −40,000 | $0.89 | $35K | 7,614 |
| 2024-12-23 | CALLICUTT JACK W Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | +40,000 | 0 | ||
| 2024-10-23 | ELDRED KARY Director | Purchase | +500 | $2.60 | $1K | 50,213 |
Page 13 of 15 · 291 trades